We're proud of our team and grateful to our study partners for being an integral part of advancing Pfizer's RSV research!
ECN is pleased to announce that our @LasVegasClinicalTrials site recently underwent a not-for-cause FDA site inspection as a high enroller on a RSV vaccine trial. The inspection resulted in no findings, demonstrating our commitment to quality and compliance in clinical research. This achievement underscores ECN’s dedication to conducting trials with the highest standards of integrity and excellence. Across 20+ locations in the USA, ECN has undergone numerous FDA inspections over the last several years with no 483. We look forward to continually upholding the highest standards for clinical research at all of our sites, ensuring robust and ethical clinical trials that advance healthcare through the highest quality data. We extend our gratitude to everyone involved in making this inspection a success, from our dedicated team to our valued partners. Stay tuned for more updates as we continue to innovate in healthcare through rigorous clinical research. #RSV #ClinicalTrials #ClinicalResearch